Remedium Lifecare Ltd board to consider preferential issue to raise Rs 100 crores equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
Connectivity solutions for data integration are critical to stop data silos and ensure success of any data monetization strategy, finds Frost & Sullivan
SANTA CLARA, Calif., May 3, 2021 /PRNewswire/ Frost & Sullivan s recent analysis
, Data Monetization Drives Innovative Business Models in the Global MedTech Industry, finds that the digitalization of the healthcare sector will lead us to broader healthcare objectives of real-world evidence and precision medicine. But to achieve those goals, we need to harness data monetization. Frost & Sullivan has developed frameworks to understand direct and indirect data monetization, assess the data monetization potential for medical devices, and harness growth using data.
»
This VC firm invested in Pharmeasy when it was valued at just $10 million – here’s why it promises to invest in every round even after an IPO
This VC firm invested in Pharmeasy when it was valued at just $10 million – here’s why it promises to invest in every round even after an IPO
Sanchita DashApr 15, 2021, 09:02 IST
Rehan Yar Khan at Orios Ventures was the man who handed one of the first cheques to API Holdings. Orios Ventures
Pharmeasy’s parent company’s API Holdings’ $1.5 billion valuation made it the first
healthtech company to be a unicorn in India.
Rehan Yar Khan at
Pharmeasy parent enters unicorn club at $1.5 billion valuation
SECTIONS
Share
Synopsis
Pharmeasy’s $350 million funding round comes at a time when Reliance, Tata Group and Amazon are looking to tap the online pharmacy business by way of acquisitions.
ETtech
Pharmaeasy is the seventh startup unicorn this year, after Cred, Meesho, Digit Insurance, Innovaccer, Infra.Market and Five Star Finance. (Illustration: Rahul Awasthi/ETtech)
Bengaluru: Prosus Ventures and US-based private equity firm TPG Capital are leading an investment of $350 million (about Rs 2,570 crore) in API Holdings, the parent company of Mumbai-based online pharmacy Pharmeasy.
Prosus Ventures (previously Naspers Ventures) is the venture investing arm of South African technology and media conglomerate Prosus, which is one of the largest investors in Indian technology startups including Swiggy, Byju s and Meesho.